GINS3 and colorectal cancer: The survival rate of the patient group with increased Psf3 expression was considerably lower than that of the reduced Psf3 expression group in NSCLC, lung adenocarcinoma, and colorectal cancer patients (Hokka et al., 2013; Sun et al., 2014; Tane et al., 2015; Tauchi et al., 2016).